Charles Cochrane, M.D., Scripps Research Institute (IMAGE)
Caption
Scripps Research Institute professor emeritus Charles Cochrane, M.D., led work that laid the foundation for the new drug Surfaxin, now approved in the United States for the treatment of infant respiratory distress syndrome.
Credit
Courtesy of The Scripps Research Institute.
Usage Restrictions
None
License
Licensed content